Month: July 2024

{{ brizy_dc_global_blocks position=’top’ }} Pharmaceuticals {{placeholder content=’e3tlZGl0b3JfYnJlYWRjcnVtYnN9fQ==’}} {{placeholder content=’e3ticml6eV9kY19wb3N0X3RpdGxlfX0=’}} An orally active antibiotic Active Substances Each ml contains: levofloxacin hemihydrate 100 mg. Description An orally active antibiotic and is active against both gram positive and gram negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV. Usage Treatment of infections caused by strains sensitive… Continue reading LEVONEXT 10

Pharmaceuticals Antibiotic with bactericidal activity. Active Substances Each ml contains: fosfomycin sodium 200 mg. Description Fosfomycin is an antibiotic with bactericidal activity that kills bacteria by inhibiting synthesis of cell walls. It has a high bioavailability, low binding to plasmatic proteins and low toxicity. Usage Treatment of bacterial infections in poultry susceptible to fosfomycin as… Continue reading FOSFONEXT 20

{{ brizy_dc_global_blocks position=’top’ }} Pharmaceuticals {{placeholder content=’e3tlZGl0b3JfYnJlYWRjcnVtYnN9fQ==’}} {{placeholder content=’e3ticml6eV9kY19wb3N0X3RpdGxlfX0=’}} A broad-spectrum antibiotic. Active Substances Each ml contains: florfenicol 200 mg. Description A broad-spectrum antibiotic that has activity against many bacteria. It acts by binding to the 50S ribosome, thereby inhibiting bacterial protein synthesis. Usage ppprophylaxis and treatment of gastrointestinal and respiratory tract infections caused by… Continue reading FLORINEXT 20

Pharmaceuticals A broad-spectrum antibiotic. Active Substances Each ml contains: florfenicol 100 mg. Description A broad-spectrum antibiotic that has activity against many bacteria. It acts by binding to the 50S ribosome, thereby inhibiting bacterial protein synthesis. Usage Prophylaxis and treatment of gastrointestinal and respiratory tract infections caused by Actinobacillus spp, Pasteurella spp, Salmonella spp, and Streptococcus… Continue reading FLORINEXT 10

{{ brizy_dc_global_blocks position=’top’ }} Pharmaceuticals {{placeholder content=’e3tlZGl0b3JfYnJlYWRjcnVtYnN9fQ==’}} {{placeholder content=’e3ticml6eV9kY19wb3N0X3RpdGxlfX0=’}} Treatment of infections. Active Substances Each ml contains: enrofloxacin 100 mg Description Treatment of infections caused by Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium paragallinarum, Pasteurella multocida. Usage treatment of infections caused by strains sensitive to enrofloxacin, as Avibacterium paragallinarum (Coryza contagiosa avium), Pasteurella spp., E. coli, Salmonella… Continue reading ENRONEXT 10

{{ brizy_dc_global_blocks position=’top’ }} Pharmaceuticals {{placeholder content=’e3tlZGl0b3JfYnJlYWRjcnVtYnN9fQ==’}} {{placeholder content=’e3ticml6eV9kY19wb3N0X3RpdGxlfX0=’}} Antipyretic,analgesic, anti-stress and anti-inflammatory Active Substances Each ml contains: ciprofloxacin 200 mg. Description Ciprofloxacin belongs to the group of quinolones and acts bactericidally against mainly Gramnegative bacteria like Campylobacter, E. coli, Haemophilus, Mycoplasma, Pasteurella and Salmonella spp. Usage Treatment of gastrointestinal, respiratory and urinary tract infections… Continue reading CIPRONEXT 20